Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin Assembly and Disassembly | 27 | 2023 | 632 | 6.950 |
Why?
|
Chromosomal Proteins, Non-Histone | 20 | 2024 | 723 | 6.170 |
Why?
|
Chromatin | 26 | 2024 | 2981 | 3.010 |
Why?
|
Transcription Factors | 37 | 2024 | 12130 | 2.770 |
Why?
|
Sarcoma, Synovial | 6 | 2021 | 157 | 2.420 |
Why?
|
Nucleosomes | 8 | 2023 | 492 | 1.850 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2022 | 1609 | 1.700 |
Why?
|
Multiprotein Complexes | 6 | 2023 | 1107 | 1.310 |
Why?
|
Mammals | 10 | 2023 | 1126 | 1.280 |
Why?
|
Nuclear Proteins | 14 | 2023 | 5791 | 1.130 |
Why?
|
Rhabdoid Tumor | 2 | 2018 | 209 | 1.020 |
Why?
|
Nobel Prize | 1 | 2024 | 46 | 0.920 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2024 | 8612 | 0.860 |
Why?
|
Disease | 2 | 2020 | 674 | 0.840 |
Why?
|
Neoplasm Proteins | 5 | 2020 | 3594 | 0.800 |
Why?
|
Liposarcoma, Myxoid | 1 | 2022 | 60 | 0.770 |
Why?
|
DNA-Binding Proteins | 11 | 2023 | 9601 | 0.720 |
Why?
|
Adenosine Triphosphatases | 3 | 2021 | 839 | 0.710 |
Why?
|
Heterochromatin | 3 | 2017 | 294 | 0.680 |
Why?
|
Histones | 6 | 2022 | 2591 | 0.650 |
Why?
|
Models, Molecular | 5 | 2022 | 5382 | 0.630 |
Why?
|
Neoplasms | 12 | 2024 | 22344 | 0.630 |
Why?
|
Ubiquitins | 1 | 2020 | 365 | 0.620 |
Why?
|
Proto-Oncogene Proteins | 4 | 2020 | 4521 | 0.610 |
Why?
|
Repressor Proteins | 3 | 2020 | 2974 | 0.600 |
Why?
|
HEK293 Cells | 8 | 2020 | 4263 | 0.600 |
Why?
|
Sarcoma | 3 | 2018 | 1801 | 0.590 |
Why?
|
Lymphoma | 6 | 2013 | 1896 | 0.570 |
Why?
|
Genetic Fitness | 1 | 2018 | 119 | 0.550 |
Why?
|
Lifting | 1 | 2016 | 56 | 0.500 |
Why?
|
Developmental Biology | 1 | 2016 | 78 | 0.500 |
Why?
|
Cell Line, Tumor | 18 | 2024 | 17071 | 0.500 |
Why?
|
Protein Subunits | 4 | 2021 | 940 | 0.490 |
Why?
|
p300-CBP Transcription Factors | 1 | 2016 | 147 | 0.480 |
Why?
|
Granulocytes | 1 | 2017 | 548 | 0.480 |
Why?
|
DNA Helicases | 7 | 2023 | 852 | 0.470 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1252 | 0.470 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 619 | 0.460 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 309 | 0.440 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 696 | 0.430 |
Why?
|
Meningioma | 1 | 2022 | 1221 | 0.430 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1027 | 0.420 |
Why?
|
Soft Tissue Neoplasms | 2 | 2020 | 1163 | 0.410 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 698 | 0.380 |
Why?
|
Complement Activation | 1 | 2013 | 431 | 0.380 |
Why?
|
Animals | 38 | 2024 | 168800 | 0.380 |
Why?
|
Protein Binding | 8 | 2021 | 9301 | 0.360 |
Why?
|
Central Nervous System Neoplasms | 3 | 2013 | 918 | 0.340 |
Why?
|
Mutation | 11 | 2023 | 30209 | 0.330 |
Why?
|
Genome, Human | 2 | 2019 | 4443 | 0.320 |
Why?
|
Enhancer Elements, Genetic | 4 | 2019 | 1363 | 0.310 |
Why?
|
Adenosine Triphosphate | 4 | 2022 | 2003 | 0.290 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3818 | 0.290 |
Why?
|
Hematopoiesis | 1 | 2017 | 2060 | 0.290 |
Why?
|
Humans | 60 | 2024 | 766117 | 0.260 |
Why?
|
SOXB1 Transcription Factors | 2 | 2021 | 283 | 0.260 |
Why?
|
Haploinsufficiency | 2 | 2024 | 334 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2327 | 0.240 |
Why?
|
Chemistry | 1 | 2024 | 325 | 0.230 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2012 | 1374 | 0.230 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2024 | 220 | 0.230 |
Why?
|
Cell Proliferation | 6 | 2024 | 10433 | 0.220 |
Why?
|
RNA Interference | 4 | 2019 | 2828 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 2795 | 0.200 |
Why?
|
Oncogenes | 3 | 2021 | 1232 | 0.200 |
Why?
|
Virus Internalization | 2 | 2023 | 503 | 0.200 |
Why?
|
Prostatic Neoplasms | 3 | 2018 | 11094 | 0.190 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4352 | 0.190 |
Why?
|
Mutation, Missense | 2 | 2020 | 2590 | 0.190 |
Why?
|
Gene Knockdown Techniques | 2 | 2018 | 1602 | 0.180 |
Why?
|
Genes, Tumor Suppressor | 2 | 2017 | 1060 | 0.180 |
Why?
|
Structural Homology, Protein | 1 | 2020 | 86 | 0.180 |
Why?
|
Histone Code | 1 | 2021 | 160 | 0.170 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 304 | 0.170 |
Why?
|
Brain Neoplasms | 4 | 2009 | 9065 | 0.170 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 697 | 0.170 |
Why?
|
DNA | 4 | 2022 | 7193 | 0.170 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2024 | 453 | 0.160 |
Why?
|
Spliceosomes | 1 | 2019 | 116 | 0.160 |
Why?
|
Gene Knockout Techniques | 2 | 2020 | 800 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2018 | 68 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 18076 | 0.150 |
Why?
|
Adenovirus E1A Proteins | 1 | 2018 | 81 | 0.150 |
Why?
|
Carcinoma, Medullary | 1 | 2019 | 115 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9378 | 0.150 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2018 | 163 | 0.150 |
Why?
|
Brachytherapy | 1 | 2005 | 1218 | 0.150 |
Why?
|
BRCA1 Protein | 1 | 2024 | 1155 | 0.150 |
Why?
|
Mutant Proteins | 1 | 2019 | 487 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2018 | 313 | 0.140 |
Why?
|
Catalysis | 1 | 2019 | 767 | 0.140 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2017 | 104 | 0.140 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1743 | 0.140 |
Why?
|
Genes, Essential | 1 | 2018 | 185 | 0.140 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 556 | 0.140 |
Why?
|
Promoter Regions, Genetic | 2 | 2018 | 5784 | 0.140 |
Why?
|
Embryonic Stem Cells | 2 | 2021 | 1242 | 0.130 |
Why?
|
Mice | 16 | 2024 | 81839 | 0.130 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 645 | 0.130 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2017 | 122 | 0.130 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2017 | 237 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 308 | 0.130 |
Why?
|
Protein Conformation | 2 | 2022 | 3946 | 0.130 |
Why?
|
RNA-Binding Protein EWS | 1 | 2017 | 211 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5336 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 1000 | 0.130 |
Why?
|
Transcription, Genetic | 3 | 2018 | 7600 | 0.120 |
Why?
|
RNA Splicing | 1 | 2019 | 902 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1227 | 0.120 |
Why?
|
Complement C5b | 1 | 2013 | 7 | 0.110 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 332 | 0.110 |
Why?
|
Complement C3a | 1 | 2013 | 64 | 0.110 |
Why?
|
Rare Diseases | 1 | 2019 | 630 | 0.110 |
Why?
|
Injections, Intraventricular | 1 | 2013 | 227 | 0.110 |
Why?
|
HeLa Cells | 1 | 2019 | 3073 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2415 | 0.110 |
Why?
|
Chemokine CXCL13 | 1 | 2013 | 62 | 0.100 |
Why?
|
Injections, Spinal | 1 | 2013 | 318 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2796 | 0.100 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1318 | 0.100 |
Why?
|
RNA Polymerase II | 1 | 2016 | 549 | 0.100 |
Why?
|
Organoids | 1 | 2018 | 740 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2206 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13635 | 0.100 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2013 | 329 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1468 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1519 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2242 | 0.090 |
Why?
|
Point Mutation | 1 | 2016 | 1591 | 0.090 |
Why?
|
DNA Methylation | 3 | 2024 | 4425 | 0.090 |
Why?
|
Phenotype | 2 | 2020 | 16716 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2195 | 0.090 |
Why?
|
Drosophila | 1 | 2018 | 1506 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1739 | 0.090 |
Why?
|
Prostate | 1 | 2018 | 1758 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9527 | 0.080 |
Why?
|
Saccharomyces cerevisiae | 1 | 2020 | 2677 | 0.080 |
Why?
|
Binding Sites | 1 | 2018 | 6001 | 0.080 |
Why?
|
DNA Replication | 1 | 2016 | 1428 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2013 | 2271 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2824 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3436 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13483 | 0.080 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1837 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 646 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6493 | 0.080 |
Why?
|
STAT6 Transcription Factor | 1 | 2009 | 196 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3448 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1883 | 0.080 |
Why?
|
Mice, Nude | 2 | 2019 | 3610 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2017 | 2864 | 0.080 |
Why?
|
DNA Modification Methylases | 1 | 2009 | 207 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6363 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13400 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1962 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2013 | 1181 | 0.070 |
Why?
|
Luminescent Measurements | 1 | 2009 | 341 | 0.070 |
Why?
|
DNA Repair Enzymes | 1 | 2009 | 342 | 0.070 |
Why?
|
Dacarbazine | 1 | 2009 | 552 | 0.060 |
Why?
|
Gene Frequency | 1 | 2013 | 3623 | 0.060 |
Why?
|
Methotrexate | 1 | 2012 | 1719 | 0.060 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9540 | 0.060 |
Why?
|
Cell Polarity | 1 | 2009 | 636 | 0.060 |
Why?
|
Genomics | 2 | 2019 | 5926 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2019 | 2010 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 5995 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18321 | 0.060 |
Why?
|
Interleukin-4 | 1 | 2009 | 1149 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3594 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2020 | 2510 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9237 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2838 | 0.050 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2023 | 93 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3111 | 0.050 |
Why?
|
Urinary Bladder | 1 | 2009 | 1155 | 0.050 |
Why?
|
Ethanol | 1 | 2009 | 1326 | 0.050 |
Why?
|
Prognosis | 3 | 2020 | 29912 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2024 | 1885 | 0.050 |
Why?
|
Female | 14 | 2024 | 396233 | 0.050 |
Why?
|
Male | 11 | 2020 | 363935 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4282 | 0.050 |
Why?
|
Immunoblotting | 2 | 2020 | 1644 | 0.050 |
Why?
|
Signal Transduction | 3 | 2022 | 23605 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2009 | 1181 | 0.050 |
Why?
|
Proteomics | 2 | 2013 | 3907 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12803 | 0.050 |
Why?
|
Liver Regeneration | 1 | 2022 | 213 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2021 | 251 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 385 | 0.040 |
Why?
|
Genetic Markers | 1 | 2006 | 2603 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2009 | 2463 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2021 | 472 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3604 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 486 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2024 | 21074 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 167 | 0.040 |
Why?
|
Lymphoma, B-Cell | 2 | 2021 | 943 | 0.040 |
Why?
|
Treatment Failure | 1 | 2005 | 2653 | 0.040 |
Why?
|
HMGB1 Protein | 1 | 2020 | 139 | 0.040 |
Why?
|
GATA3 Transcription Factor | 1 | 2020 | 163 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2018 | 102 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 155 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2020 | 22228 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 328 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2021 | 559 | 0.040 |
Why?
|
Guanosine Triphosphate | 1 | 2018 | 314 | 0.040 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2018 | 187 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2020 | 855 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 874 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3665 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1695 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 18967 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2017 | 205 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 561 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2017 | 189 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 713 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 615 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2009 | 4044 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12827 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 778 | 0.030 |
Why?
|
Antioxidants | 1 | 2023 | 1671 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 784 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 963 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5695 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59515 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 902 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 1967 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 872 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2020 | 1017 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2017 | 856 | 0.030 |
Why?
|
Macrophages | 1 | 2009 | 5776 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 840 | 0.030 |
Why?
|
Rabbits | 1 | 2020 | 4730 | 0.030 |
Why?
|
Middle Aged | 7 | 2020 | 223083 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8525 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11906 | 0.030 |
Why?
|
Infusions, Intraventricular | 1 | 2012 | 31 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2018 | 3051 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1322 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 740 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 998 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3159 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 3584 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2815 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1750 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1490 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1852 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2020 | 1725 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2927 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2020 | 1704 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2039 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1331 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2920 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2593 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2019 | 2445 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7582 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1437 | 0.020 |
Why?
|
Epigenomics | 1 | 2016 | 959 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14645 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 596 | 0.020 |
Why?
|
Sirolimus | 1 | 2017 | 1541 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3424 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2536 | 0.020 |
Why?
|
Adult | 5 | 2020 | 223139 | 0.020 |
Why?
|
Aged | 4 | 2020 | 171219 | 0.020 |
Why?
|
Zebrafish | 1 | 2020 | 3035 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5747 | 0.020 |
Why?
|
Goserelin | 1 | 2009 | 126 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2879 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36427 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6506 | 0.020 |
Why?
|
Mice, SCID | 1 | 2013 | 2626 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6892 | 0.020 |
Why?
|
Antithrombin III | 1 | 2007 | 128 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2630 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42511 | 0.020 |
Why?
|
Eye Neoplasms | 1 | 2009 | 305 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1663 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15546 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4162 | 0.020 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2007 | 181 | 0.020 |
Why?
|
Drug Therapy | 1 | 2009 | 504 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 505 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4565 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5020 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2009 | 547 | 0.020 |
Why?
|
Genetic Variation | 1 | 2020 | 6612 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6102 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 88819 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 695 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2007 | 992 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7072 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8494 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10860 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 12976 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20137 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2009 | 1273 | 0.010 |
Why?
|
Radiotherapy | 1 | 2009 | 1491 | 0.010 |
Why?
|
Child | 2 | 2020 | 80573 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9521 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10260 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1600 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1535 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 30233 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3801 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22341 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39243 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12775 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1433 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41684 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40108 | 0.010 |
Why?
|
Immunotherapy | 1 | 2009 | 4746 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59868 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20700 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 74857 | 0.000 |
Why?
|